Applications of 18FFDG PETCT for accurate radiotherapy of esophageal cancer

Abstract

Wei Li, Li Duojie. Applications of 18FFDG PETCT for accurate radiotherapy of esophageal cancer[J]. Journal of International Oncology, 2015, 42(12): 928-931.

［1］ Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a metaanalysis［J］. Lancet Oncol, 2007, 8(3): 226-234. ［2］ Tan S, Kligerman S, Chen W, et al. Spatialtemporal ［18F］ FDGPET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy［J］. Int J Radiat Oncol Biol Phys, 2013, 85(5): 1375-1382. ［3］ Macmanus M, Nestle U, Rosenzweig KE, et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 20062007［J］. Radiother Oncol, 2009, 91(1): 85-94. ［4］ Muijs CT, Beukema JC, Pruim J, et al. A systematic review on the role of FDGPET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer［J］. Radiother Oncol, 2010, 97(2): 165-171. ［5］李军凯, 左效艳, 许文, 等. PET/CT对于食管癌放射治疗的研究进展［J］. 中国医药导刊, 2012, 14(8): 1311-1313. ［6］李娟, 祝淑钗, 刘志坤, 等. (18)FFDG PET和CT对食管癌临床分期的价值［J］. 中国肿瘤临床, 2011, 38(23): 1449-1452. ［7］李娟, 祝淑钗, 刘志坤, 等. 超声内镜结合CT扫描在食管癌临床分期中的应用［J］. 中国肿瘤临床, 2011, 38(1): 46-49. ［8］ Seol KH, Lee JE. PET/CT planning during chemoradiotherapy for esophageal cancer［J］. Radiat Oncol J, 2014, 32(1): 31-42. ［9］ Jeganathan R, Mcguigan J, Campbell F, et al. Does preoperative estimation of oesophageal tumour metabolic length using 18Ffluorodeoxyglucose PET/CT images compare with surgical pathology length?［J］. Eur J Nucl Med Mol Imaging, 2011, 38(4): 656-662. ［10］ Wang F, Shen LY, Ma SH, et al. Advantages of positron emission tomographycomputed tomography imaging in esophageal squamous cell carcinoma［J］. Dis Esophagus, 2013, 26(8): 832-837. ［11］ Karashima R, Watanabe M, Imamura Y, et al. Advantages of FDGPET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer［J］. Surg Today, 2015, 45(4): 471-477. ［12］ Tan R, Yao SZ, Huang ZQ, et al. Combination of FDG PET/CT and contrastenhanced MSCT in detecting lymph node metastasis of esophageal cancer［J］. Asian Pac J Cancer Prev, 2014, 15(18): 7719-7724. ［13］ Kato H, Kimura H, Nakajima M, et al. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer［J］. Oncol Rep, 2008, 20(4): 857-862. ［14］ Liu CJ, Cheng JC, Lee JM, et al. Patterns of nodal metastases on 18FFDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy［J］. Clin Nucl Med, 2015, 40(5): 384-389. ［15］谢彦婷, 郑荣, 吴宁, 等. 食管癌IMRT前FDG PETCT显像对治疗决策的影响［J］. 中华放射肿瘤杂志, 2014, 23(1): 31-34. ［16］ Schreurs LM, Busz DM, Paardekooper GM, et al. Impact of 18fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal interobserver variability: PET/CT improves esophageal target definition［J］. Dis Esophagus, 2010, 23(6): 493-501. ［17］ Nkhali L, Thureau S, EdetSanson A, et al. FDGPET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses［J］. Acta Oncol, 2015, 54(6): 909-915. ［18］ Yu W, Cai XW, Liu Q, et al. Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDGPET/CT for esophageal cancer［J］. Radiother Oncol, 2015, 114(2): 195-200. ［19］ Huang JW, Yeh HL, Hsu CP, et al. To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDGPET/CT scan［J］. J Chin Med Assoc, 2015, 78(4): 229-234. ［20］ Park JS, Choi JY, Moon SH, et al. Response evaluation after neoadjuvant chemoradiation by positron emission tomographycomputed tomography for esophageal squamous cell carcinoma［J］. Cancer Res Treat, 2013, 45(1): 22-30.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[4]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[5]	Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209.
[6]	Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156.
[7]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.
[8]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.
[9]	Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552.
[10]	Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition）[J]. Journal of International Oncology, 2023, 50(7): 385-397.
[11]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367.
[12]	Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376.
[13]	Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy （2023 version）[J]. Journal of International Oncology, 2023, 50(4): 193-201.
[14]	Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance[J]. Journal of International Oncology, 2023, 50(4): 227-230.
[15]	Shi Xaioqi, Wang Hongyan.Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247.

Applications of 18FFDG PETCT for accurate radiotherapy of esophageal cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments